Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: a report from the Children's Oncology Group - Ater, J L; Xia, C; Mazewski, C M (Cancer, 2016)
, et al.